Join to View Full Profile
5 E 98th StNew York, NY 10029
Phone+1 212-241-5493
Fax+1 212-831-3324
Dr. Yong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an academic neurosurgeon with a clinical and research interest in malignant brain tumors. I completed medical school and residency training in Canada, as well as research training at MD Anderson Cancer Center, and fellowship training at the Surgical Neurology Branch, NIH Clinical Center. My laboratory focuses on characterizing genomic evolutionary dynamics in diffuse gliomas.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Neurosurgical Oncology, 2010 - 2013
University of British ColumbiaFRCSC, Residency in Neurosurgery, 2002 - 2010
University of Texas M. D. Anderson Cancer CenterMS, Cancer Biology, 2006 - 2008
University of Calgary Faculty of MedicineClass of 2002, MD
Certifications & Licensure
NY State Medical License 2013 - 2026
Royal College of Physicians and Surgeons of CanadaNeurosurgery
Awards, Honors, & Recognition
- American Brain Tumor Association Young Investigator Award AANS/CNS Section on Tumors
- Preuss Award for Basic Neurosurgical Research AANS/CNS Section on Tumors
Publications & Presentations
PubMed
- EGFR alteration is an adverse prognostic factor in IDH-mutant astrocytoma.Cheyanne C Slocum, Phuong Nguyen, Meenakshi Vij, Raymund L Yong, Jorge Samanamud
Acta Neuropathologica. 2025-08-19 - Prediction of Diffuse High-Grade Glioma Survival Outcomes Using Preoperative Whole-Brain Tractography-Based Resectability Metrics.Noah M Nichols, Nitish Seenarine, Chi H Le, Xinyan Liu, Raymund L Yong
Neurosurgery. 2025-08-07 - Spatial Multi-omics Defines a Shared Tumor Infiltrative Signature at the Resection Margin in High-Grade Gliomas.Balagopal Pai, Susana Isabel Ramos, Wan Sze Cheng, Tanvi Joshi, Emine Özen
Cancer Research. 2025-08-04
Journal Articles
- Review Comparison of Glioblastoma (GBM) Molecular Classification MethodsRaymund Yong, MD, ScienceDirect
Press Mentions
Mount Sinai & Sema4 Scientists Identify Biomarker for Progression and Drug Response in Brain CancerOctober 16th, 2017
Mount Sinai, Sema4 Data Scientists Tout Brain Cancer BreakthroughOctober 16th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
